FDA delays Sancuso PDUFA date again

ProStrakan (LSE:PSK) said FDA postponed the PDUFA date for an NDA for Sancuso because of resource constraints for a second time. A decision is now expected the week of July 7. In April, the agency pushed the action date for the transdermal granisetron patch to prevent chemotherapy-induced nausea and vomiting (CINV) back six weeks, to June 10 from May 2 (See BioCentury Extra, Wednesday, April 23, 2008). ...